» Articles » PMID: 12787756

Natural Killer Cell Receptor Signaling

Overview
Publisher Elsevier
Date 2003 Jun 6
PMID 12787756
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cell immune responses are regulated by a balance of activating and inhibitory signals transmitted by cell surface receptors. Immunoreceptor tyrosine-based inhibition motifs in the cytoplasmic domains of inhibitory NK receptors recruit tyrosine or lipid phosphatases, which modulate the activation signals transmitted by receptors linked to the Syk and ZAP70 tyrosine kinases and phosphatidylinositol-3 kinases. In addition, recent studies of gene-deficient animals, in particular Syk and ZAP70 double-deficient mice, suggest that NK cells possess a robust and potentially redundant receptor system to ensure their development and function.

Citing Articles

Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers.

Hao F, Yan Z, Shen L, Hui W, Ling Q, Xiaoyu Y J Ovarian Res. 2025; 18(1):14.

PMID: 39863894 PMC: 11762100. DOI: 10.1186/s13048-025-01592-8.


Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity.

van Vliet A, van den Hout M, Steenmans D, Duru A, Georgoudaki A, de Gruijl T Mol Ther Oncol. 2024; 32(4):200870.

PMID: 39346765 PMC: 11426129. DOI: 10.1016/j.omton.2024.200870.


Cell-cell communication: new insights and clinical implications.

Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J Signal Transduct Target Ther. 2024; 9(1):196.

PMID: 39107318 PMC: 11382761. DOI: 10.1038/s41392-024-01888-z.


Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Millan A, Allain V, Nayak I, Aguilar O, Arakawa-Hoyt J, Ureno G bioRxiv. 2024; .

PMID: 39026749 PMC: 11257556. DOI: 10.1101/2024.07.09.602676.


Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation.

Cubitt C, Wong P, Dorando H, Foltz J, Tran J, Marsala L J Clin Invest. 2024; 134(15).

PMID: 38805302 PMC: 11291271. DOI: 10.1172/JCI173602.